Get the Stockscreener App
2.16
1.41%
0.03
After Hours:
2.13
-0.03
-1.39%
Phio Pharmaceuticals Corp stock is traded at $2.16, with a volume of 66,685.
It is up +1.41% in the last 24 hours and down -0.92% over the past month.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
See More
Previous Close:
$2.13
Open:
$2.19
24h Volume:
66,685
Relative Volume:
0.07
Market Cap:
$12.37M
Revenue:
-
Net Income/Loss:
$-11.66M
P/E Ratio:
-0.2648
EPS:
-8.156
Net Cash Flow:
$-11.09M
1W Performance:
-11.48%
1M Performance:
-0.92%
6M Performance:
+67.44%
1Y Performance:
-34.74%
1-Day Range:
$2.11
$2.19
1-Week Range:
$2.0636
$2.57
52-Week Range:
$0.9657
$9.79
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Name
Phio Pharmaceuticals Corp
Sector
Industry
Phone
(508) 767-3861
Address
411 SWEDELAND ROAD, KING OF PRUSSIA, MA
Compare PHIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHIO
Phio Pharmaceuticals Corp
|
2.16 | 12.20M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-25 | Resumed | H.C. Wainwright | Buy |
| Aug-05-20 | Initiated | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp Stock (PHIO) Latest News
Resistance Check: Does Phio Pharmaceuticals Corp have declining or rising EPSJuly 2025 Analyst Calls & Expert-Curated Trade Recommendations - خودرو بانک
Will Phio Pharmaceuticals Corp face regulatory challengesJuly 2025 Drop Watch & Breakout Confirmation Alerts - خودرو بانک
Measuring Phio Pharmaceuticals Corp.’s beta against major indicesWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Is Phio Pharmaceuticals Corp forming a breakout patternWeekly Volume Report & Weekly Setup with ROI Potential - خودرو بانک
Published on: 2025-09-16 04:05:43 - خودرو بانک
Aug Catalysts: Is Phio Pharmaceuticals Corp stock a buy or sell2025 Year in Review & Fast Gaining Stock Reports - خودرو بانک
Aug Gainers: Is Phio Pharmaceuticals Corp. forming a breakout patternJuly 2025 Drop Watch & Risk Controlled Swing Trade Alerts - خودرو بانک
Will Phio Pharmaceuticals Corp. benefit from macro trendsJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com
Quarterly Trades: Can Phio Pharmaceuticals Corp sustain its profitabilityJuly 2025 Breakouts & AI Driven Price Forecasts - خودرو بانک
Using R and stats models for Phio Pharmaceuticals Corp. forecastingIndex Update & Risk Controlled Swing Trade Alerts - newser.com
Key metrics from Phio Pharmaceuticals Corp.’s quarterly data2025 Market Outlook & Verified Momentum Stock Alerts - newser.com
Earnings visualization tools for Phio Pharmaceuticals Corp.July 2025 Decliners & Community Consensus Picks - newser.com
Technical signs of recovery in Phio Pharmaceuticals Corp.Market Trend Review & Safe Capital Preservation Plans - newser.com
Will Phio Pharmaceuticals Corp. see short term momentumPortfolio Update Summary & Safe Capital Growth Tips - newser.com
What high frequency data says about Phio Pharmaceuticals Corp.Wall Street Watch & Verified Trade Idea Suggestions - Newser
Long term hold vs stop loss in Phio Pharmaceuticals Corp.2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - Newser
Using AI based signals to follow Phio Pharmaceuticals Corp.2025 Big Picture & AI Powered Trade Plan Recommendations - Newser
Is Phio Pharmaceuticals Corp. reversing from oversold territoryWeekly Volume Report & Real-Time Market Sentiment Reports - Newser
Price momentum metrics for Phio Pharmaceuticals Corp. explainedJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - Newser
Intraday pattern recognizer results for Phio Pharmaceuticals Corp.2025 Short Interest & Risk Adjusted Swing Trade Ideas - Newser
Is Phio Pharmaceuticals Corp. stock entering bullish territoryBreakout Watch & Real-Time Volume Analysis Alerts - Newser
Multi factor analysis applied to Phio Pharmaceuticals Corp.Market Trend Summary & Accurate Trade Setup Notifications - Newser
Building trade automation scripts for Phio Pharmaceuticals Corp.July 2025 Recap & Reliable Entry Point Trade Alerts - Newser
Will Phio Pharmaceuticals Corp. price bounce be sustainablePortfolio Update Summary & Low Drawdown Trading Strategies - Newser
Is Phio Pharmaceuticals Corp. stock bottoming outTrade Entry Report & Weekly Momentum Picks - Newser
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz - RTTNews
Live market analysis of Phio Pharmaceuticals Corp.2025 Analyst Calls & Fast Moving Market Watchlists - Newser
Analyzing net buyer seller activity in Phio Pharmaceuticals Corp.Quarterly Trade Review & Daily Risk Controlled Trade Plans - Newser
Combining machine learning predictions for Phio Pharmaceuticals Corp.July 2025 Decliners & Weekly Top Performers Watchlists - Newser
Will Phio Pharmaceuticals Corp. benefit from rising consumer demandEarnings Growth Summary & Daily Growth Stock Investment Tips - خودرو بانک
Can Phio Pharmaceuticals Corp. lead its sector in growthJuly 2025 Pullbacks & Reliable Entry Point Trade Alerts - خودرو بانک
Can Phio Pharmaceuticals Corp. sustain its profitabilityJuly 2025 Trade Ideas & Capital Efficient Trade Techniques - خودرو بانک
Relative strength of Phio Pharmaceuticals Corp. in sector analysis - Newser
Should you wait for a breakout in Phio Pharmaceuticals Corp.Weekly Market Report & Risk Controlled Swing Alerts - Newser
Can a trend reversal in Phio Pharmaceuticals Corp. lead to recovery2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Is Phio Pharmaceuticals Corp. gaining market shareEarnings Recap Summary & Precise Buy Zone Tips - خودرو بانک
What’s the RSI of Phio Pharmaceuticals Corp. stockDividend Hike & AI Powered Market Trend Analysis - خودرو بانک
How to integrate Phio Pharmaceuticals Corp. into portfolio analysis toolsDividend Hike & Daily Entry Point Trade Alerts - Newser
Market reaction to Phio Pharmaceuticals Corp.’s recent newsJuly 2025 Decliners & Smart Investment Allocation Insights - Newser
Is Phio Pharmaceuticals Corp. stock poised for growthWeekly Stock Summary & Proven Capital Preservation Methods - Newser
How sentiment analysis helps forecast Phio Pharmaceuticals Corp.Earnings Overview Report & Risk Controlled Daily Trade Plans - Newser
What is the Moat Score of Phio Pharmaceuticals Corp.Weekly Profit Summary & Weekly Return Optimization Plans - خودرو بانک
How to read the order book for Phio Pharmaceuticals Corp.2025 Technical Patterns & Intraday High Probability Alerts - Newser
Is a relief rally coming for Phio Pharmaceuticals Corp. holdersJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - Newser
Heatmap analysis for Phio Pharmaceuticals Corp. and competitorsMarket Activity Report & Expert-Curated Trade Recommendations - Newser
Phio Pharmaceuticals Corp. Shows Support at Fibonacci LevelAnalyst Upgrade & Free Fast Gain Swing Trade Alerts - beatles.ru
What moving averages say about Phio Pharmaceuticals Corp.Quarterly Trade Review & Technical Pattern Based Buy Signals - Newser
Phio Pharmaceuticals shares fall 1.92% after-hours as clinical trial advances to final cohort. - AInvest
Phio Pharmaceuticals to Attend Global Investment Conference - TipRanks
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference - TradingView
Final Cohort Update: Phio Pharmaceuticals' Skin Cancer Trial Progress to be Revealed at HCW Conference - Stock Titan
Phio Pharmaceuticals Corp Stock (PHIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):